Press Release

Jamjoom Pharma in Saudi Arabia Selects IQVIA's OCE Solution

Apr 01, 2021

[April 1, 2021] IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced that Jamjoom Pharma has selected IQVIA Technologies’ Orchestrated Customer Engagement (OCE) platform as its CRM solution.

“Jamjoom Pharma is eager to optimize its smart engagement with customers using IQVIA’s OCE solution,” Jamjoom Pharma Senior Director of Sales and Marketing, Dr. Wagih El Bokl, said. “IQVIA’s OCE will enhance customer engagement with precise targeting and the right content. It will enrich Jamjoom Pharma’s deeply rooted communication with the medical community, reflect positively on the company performance and sustainability, and maximize profitability.”

IQVIA’s OCE for advanced customer engagement breaks down silos by seamlessly connecting sales, account management, marketing, and other functions to enhance the customer experience, strengthen relationships and drive performance. OCE is a SaaS-based platform built on best-in-class technologies such as Salesforce, Mulesoft, Heroku and others. With unique capabilities, such as predictive analytics and machine learning, OCE provides an intuitive user experience, AI-enabled recommendations, fluid integration with other applications to deliver smarter, coordinated engagements with healthcare professionals.

“We are thrilled to work with Jamjoom to support their company’s digital transformation using OCE” said Mohamed Mostafa, General Manager for IQVIA in Saudi Arabia and Egypt. “We look forward to our partnership as we begin to implement OCE in Saudi Arabia.”

Jamjoom Pharma joins more than 140 other life sciences customers that have selected IQVIA’s OCE solution to drive market momentum and advance customer engagement.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

About Jamjoom Pharma

Jamjoom Pharma is a world-class research-driven leading pharmaceutical company. Having 20 years in GMP Pharmaceutical manufacturing in Saudi Arabia and the Middle East countries. Jamjoom Pharma's commitment reflects in its mission, which is to be a Center of Excellence in Health Care, providing high quality, safe and effective products to meet regional needs. Today, Jamjoom Pharma is the 3rd largest pharmaceutical company in the Kingdom of Saudi Arabia and the second-best prescribed company. Jamjoom Pharma is rated as the 'one of the fastest-growing pharmaceutical company' in Saudi Arabia as well as in more than 30 countries where it operates.

Contact Us